financetom
Business
financetom
/
Business
/
S&P Assigns Rating to Dye & Durham; Down Nearly 1%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&P Assigns Rating to Dye & Durham; Down Nearly 1%
Mar 22, 2024 7:54 AM

10:31 AM EDT, 03/22/2024 (MT Newswires) -- S&P Global Ratings said Thursday that it has assigned its B issuer credit rating to Dye & Durham Ltd. ( DYNDF ) .

This reflects its relatively small scale, operations in a niche segment of the legal industry, adjusted debt-to-EBITDA of about 6.3x, and concentrated ownership while acknowledging the company's diverse customer base and track record of high margins and steady free cash flow generation, the rating agency said.

At the same time, the agency assigned its B issue-level rating to the company's proposed $495 million of seven-year senior secured term loan B and $680 million of other secured debt.

"The stable outlook reflects our expectations that the company's revenues and EBITDA will benefit from increasing transaction volumes as well as growing annual recurring revenue (ARR). The rating also captures management's ambitious growth strategy," S&P said.

The company's stock slipped nearly 1% on last look on Friday.

Price: 15.43, Change: -0.19, Percent Change: -1.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Capricor Therapeutics Stock Friday?
What's Going On With Capricor Therapeutics Stock Friday?
Jun 28, 2024
Capricor Therapeutics, Inc. ( CAPR ) shares are trading higher on Friday. The company announced the long-term benefits of deramiocel for the treatment of duchenne muscular dystrophy (DMD). What Happened: The biotechnology company said deramiocel increased cardiac function based on several different measures. The study found improvements in left ventricular ejection fraction, left ventricular end systolic volume and left ventricular end...
What's Going On With Innovative Eyewear Stock?
What's Going On With Innovative Eyewear Stock?
Jun 28, 2024
Innovative Eyewear, Inc. ( LUCY ) shares are surging higher Friday on heavy trading volume. Here's a look at what's going on. What To Know: Last week Innovative Eyewear ( LUCY ) provided a sales and marketing update. The company highlighted its new partnership with Windsor Eyes, a distributor for select US optical and big box channels, and said it...
Apple's AI Strategy Seen Driving Revenue, Earnings Growth Faster Than Expected, Oppenheimer Says
Apple's AI Strategy Seen Driving Revenue, Earnings Growth Faster Than Expected, Oppenheimer Says
Jun 28, 2024
01:00 PM EDT, 06/28/2024 (MT Newswires) -- Apple's ( AAPL ) move to incorporate artificial intelligence in iPhone, iPad, and Mac, is likely to add fuel to an anticipated revenue and earnings growth, Oppenheimer said in a Friday note. Apple Intelligence is expected to advance hardware replacement and help iPhone, iPad and Mac gain market share, the investment firm said....
Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut
Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut
Jun 28, 2024
June 28 (Reuters) - Shares of biopharmaceutical firm Alumis opened nearly 16% below their initial public offering (IPO) price in their debut on the Nasdaq on Friday. A long-awaited recovery in the IPO market that began earlier this year has begun to sputter as the U.S. Federal Reserve continues to delay interest rate cuts, which has also hampered trading in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved